| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Carisma Therapeutics Inc. (CARM) has 1 insider with recent SEC Form 4 filings, including 0 buys and 19 sells. CARM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 57.0K | $22.79 | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 7, 2025 | Klichinsky Michael | Chief Scientific Officer | Sale+OE | 56,982 | $0.25 | $14,484.82 | -100% | |
| Oct 3, 2025 | Klichinsky Michael | Chief Scientific Officer | Sell | 484,347 | $0.26 | $124,342.96 | -52.5% | |
| Mar 2, 2023 | Cannell Thomas R | President And CEO | Sale+OE | 487,487 | $0.59 | $286,154.87 | -32.4% | |
| Mar 2, 2023 | Sullivan Mark | General Counsel &Secretary | Sale+OE | 219,218 | $0.59 | $128,680.97 | -19.8% | |
| Mar 2, 2023 | Forbes Monica | Chief Financial Officer | Sale+OE | 345,849 | $0.59 | $203,013.36 | -21.6% | |
| Mar 2, 2023 | MacDonald Glen C | Chief Technology Officer | Sale+OE | 170,372 | $0.59 | $100,008.36 | -15.4% | |
| Mar 2, 2023 | Ryu Elly | Principal Accounting Officer | Sell | 17,289 | $0.59 | $10,148.64 | -10.4% | |
| Feb 21, 2023 | Sullivan Mark | General Counsel &Secretary | Sell | 39,831 | $0.59 | $23,392.75 | -11.7% | |
| Feb 21, 2023 | Ryu Elly | Principal Accounting Officer | Sell | 7,159 | $0.59 | $4,204.48 | -4.1% | |
| Feb 21, 2023 | Cannell Thomas R | President And CEO | Sell | 53,727 | $0.59 | $31,553.87 | -8.9% |